Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 22, pseudogene (RNU6-22P) is a human gene annotated as a pseudogene, meaning it shares sequence similarity to functional U6 small nuclear RNA genes but does not produce a functional RNA or protein. It is catalogued in genome databases (HGNC:34266, NCBI Gene:106478917, Ensembl:ENSG00000207083). U6 snRNA genes code for small nuclear RNAs involved in the spliceosome and intron removal from pre-mRNA, but pseudogenes like RNU6-22P have lost this functionality, either because they are not expressed or because their sequence is no longer capable of fold and function. In the context of molecular targeting, RNU6-22P does not serve as an enzyme, receptor, transporter, or therapeutic target. If you seek information about functional U6 small nuclear RNA, review canonical U6 snRNA gene entries such as RNU6-1, which is involved in pre-mRNA splicing and has biological and biomarker relevance. However, RNU6-22P itself does not have direct biological or clinical significance.
None (no mechanisms of action relevant to this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 22, pseudogene (RNU6-22P).